Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Benitec Biopharma divulges ddRNAi agents for pain

Sep. 20, 2013

Rottapharm patents novel orexin OX1 receptor antagonists

Sep. 19, 2013

GW Pharmaceuticals begins phase I study of cannabinoid GWP-42006 for epilepsy

Sep. 19, 2013

Eslicarbazepine acetate meets primary endpoint in two phase III epilepsy studies

Sep. 19, 2013

Acacia Pharma initiates phase III studies of APD-421 for PONV

Sep. 19, 2013

First muscarinic acetylcholine M5 receptor NAM discovered

Sep. 18, 2013

Novel PDE10A inhibitors described by Lundbeck

Sep. 18, 2013

Alemtuzumab approved for multiple sclerosis in the E.U.

Sep. 17, 2013

Evotec AG and Harvard Stem Cell Institute form CureMN collaboration

Sep. 17, 2013

Oligomerix receives NIH grant for Alzheimer's disease therapeutic discovery

Sep. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...